Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Peganone
Synonyms :
ethotoin
Class :
Anticonvulsants
Brand Name :
Peganone
Synonyms :
ethotoin
Class :
Anticonvulsants
Dosage Forms & Strengths  Â
Tablet Â
250 mg Â
Indicated for Tonic Clonic & Complex Partial Seizures :
1
g/day
Orally 
in 4-6 divided doses; may be increased up to 2-3 g/day
Dosage Forms & Strengths  Â
Tablet Â
250 mg Â
Indicated for Tonic Clonic & Complex Partial Seizures :
750
mg/day
Orally 
in 4-6 divided doses; increased up to 500 mg-1 g/day
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
relugolix/estradiol/norethindrone
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism
may increase the level by affecting the hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may increase the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
may decrease the level by affecting hepatic enzyme CYP3A4 metabolism
The potential for CNS depression may enhanced when ethotoin is used together with fencamfamin
When ethotoin is used together with niaprazine, the risk or seriousness of CNS depression is enhanced
When ethotoin is used together with melitracen, this leads to enhanced risk or seriousness of CNS depression
ethotoin: it may increase the central nervous system depressant activities of tolperisone
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
may decrease the levels by unspecified interaction mechanism
may decrease the levels by unspecified interaction mechanism
may decrease the levels by unspecified interaction mechanism
may decrease the levels by unspecified interaction mechanism
may decrease the levels by unspecified interaction mechanism
may increase the risk of sedation
may increase the risk of sedation
may increase the risk of sedation
may increase the risk of sedation
may increase the risk of sedation
may enhances the effects of the other by pharmacodynamic synergism
may enhances the effects of the other by pharmacodynamic synergism
may enhances the effects of the other by pharmacodynamic synergism
may enhances the effects of the other by pharmacodynamic synergism
may enhances the effects of the other by pharmacodynamic synergism
It may enhance the risk of adverse effects when combined with Anticonvulsants
Adverse drug reactions Â
Frequency Not Defined Â
Headache Â
Insomnia Â
Dizziness Â
Rash Â
Diarrhea Â
Mild nausea Â
Fatigue Â
Diplopia Â
Nystagmus Â
Numbness Â
Vomiting Â
Chest pain Â
Pregnancy warnings:   
AU TGA pregnancy category: DÂ
Lactation: Â
Excreted into human milk is known Â
Pregnancy Categories:       Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category Â
 Â
Patient Information Leaflet   Â
Generic Name: ethotoinÂ
Why do we use ethotoin? Â
ethotoin is an Anticonvulsants used to treat Tonic Clonic & Complex Partial SeizuresÂ
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
